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ABSTRACT: Cryptosporidium par vum, a protozoan parasite infecting 
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epithelial cells lining the intestinal tract of animals and humans, causes 
fulminate diarrhea and malabsorption of essential nutrients following 
damage to the cellular brush border. The present study was undertaken to 
evaluate the use of a pentose sugar (D-xylose) in a standardized tolerance test 
as an indicator of malabsorption due to cryptosporidiosis in the 
dexamethasone (DEX)-immunosuppressed adult C57BL/6N mouse model. 
One group containing 14 experimental mice (in addition to appropriate 
control groups) was immunosuppressed using daily intraperitoneal 
injections of DEX (125 µg/mouse). On day 7 postimmunosuppression, mice 
were inoculated orally with 104 C. parvum oocysts/mouse. Approximately 1 
month postinoculation, feces from individual mice were checked for oocyst 
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shedding using an indirect immunofluorescent assay to confirm patent 
infections. After 24 hours of fasting, infected mice were administered D-
xylose (2.5 mg/ g body weight) by gavage. Mice were killed at either 45 or 90 
minutes post-D-xylose administration, blood was collected from the chest 
cavity, and the serum was harvested. Sections of the proximal duodenum 
and distal ileum of each mouse were histologically prepared for quantitation 
of C. parvum using brightfield microscopy. Serum was analyzed with a 
spectrophotometer (520 nm) by employing a calorimetric reaction as a 
measure of the absorptive capacity of D-xylose in the small intestine of C. 
parvum-infected mice. Statistical analysis revealed no significant correlation 
between the number of parasites present and intestinal absorption of D-
xylose. However, administration of DEX was positively correlated to D-xylose 
absorption. These findings indicate that the xylose tolerance test is 
inappropriate in the adult C57BL/6N mouse model for evaluating 
malabsorption due to cryptosporidiosis in the presence of DEX. 
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INTRODUCTION 
Cryptosporidium parvum is a widespread protozoan parasite shown to 
cause diarrhea in humans and animals. A common route of infection is 
through fecal-oral means (17). Diarrhea ranges from moderately severe in 
immunocompetent individuals to a life threatening, cholera-like illness in 
immunocompromised individuals . This parasite has recently received 
greater attention due to its impact on patients with acquired 
immunodeficiency syndrome. C. parvum commonly manifests itself with 
clinical symptoms of fever associated with abdominal pain and chronic 
diarrhea causing weight loss (3). The differences between 
immunocompromised host and immunocompetent host reactions to C. 
parvum infection suggest that significant differences exist between intestinal 
tract responsiveness of the two groups. 
Currently there are no effective treatments for C. parvum infection 
and consequently an accelerated effort is underway to develop methods of 
studying the organism. Improved understanding of C. parvum will certainly 
help develop effective treatments in the near future. In vitro and in vivo 
methods of investigating biological properties of this organism in our 
laboratory at Utah State University will undoubtedly contribute towards an 
effective treatment. An effective chemotherapy directed towards 
gastrointestinal tract treatment could offer hope of preventing magnification 
of the disease. 
Infection has been observed in several regions of the intestinal tract in 
different species but it is most commonly found in the distal intestine and in 
the colon. The detrimental effects of this infection on the villi of the 
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intestine have been well documented (5, 12). Such effects as intestinal 
dysfunction, villous atrophy and crypt hypertrophy have been noted. These 
effects have also been related to decreased absorption of nutrients by intestinal 
cells (11). An effective agent to study malabsorption will aid further studies of 





In 1912, E. E. Tyzzer identified Cryptosporidium parvum as a 
protozoan parasite in the phylum Apicomplexa, class Sporozoasida, order 
Eucoccidiorida, and family Cryptosporidiidae(18). For many years after the 
initial identification, little research was done on C. parvum until it was 
identified as a possible cattle pathogen (14). This led to increased interest in 
studies of this parasite. Recently, more interest has developed due to 
increased number of immunodeficient humans such as those with AIDS. An 
infection with C. parvum in these individuals is very detrimental and often 
life-threatening . 
Life cycle 
Cryptosporidium parvum is a small (2-S)um depending on stage in life 
cycle) coccidian parasite that, for the most part, infects the respiratory tree, the 
gastrointestinal tract, and associated organs (8). Infection can be identified by 
watery diarrhea, emaciation, and intestinal villous atrophy (8, 10, 12). The 
infective stage of its life is the thick-walled oocyst produced from fertilization 
of the macrogamete (an equivalent of an ovum) by the microgamete (the 
equivalent of sperm) (8). The life cycle is illustrated in Figure 1. The mode of 
transmission is typically through food and/ or water contaminated by feces of 
an infected host . Once the oocysts are ingested, they develop into the 
sporozoite which develops into the trophozoite that infects a new host's 
epithelial cells. This develops into a Type I meront which either continues 
through the cycle and develops into a Type II meront or returns to infect a 
different epithelial cell in the host. The infection of a host cell requires that 
the sporozoites excyst from the oocyst and attach to the intestinal villi. The 
host cell membrane then encapsulates the sporozoite and thin membranes 
envelop the parasite. The encapsulation process of the oocysts can lead to 
decreased microvillar disaccharidases and forms vacuoles containing clear 
fluid . This is thought to cause damage to the absorptive capacities of the villi 
(4, 13). 
Though many agents have been tested as possible treatments, as of yet, 
there is no known effective chemotherapeutic treatment for 
cryptospori dio sis. 
Analysis of Malabsorption 
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A nutrient absorption analysis can be used to analyze damage in the 
intestinal tract of an individual. Several agents, such as fat and vitamin A, 
are commonly used to test malabsorption (6, 7, 19). To ensure proper analysis, 
it is necessary to use agents which can be easily identified (16). This can be 
done by either radiologically labeling the test agent or by using one that is not 
commonly found in the system. Both methods have been used but their 
reliability can be influenced by physiological variations of the patient . 
Specifically, the absorption site can vary greatly depending on the species (9). 
This differentiation can be due to such things as the individual environment 
and the particular diet of the test organism. 
A common analysis of malabsorption can be done by employing a 
calorimetric reaction. The method was first detailed by Roe and Rice (15). 
Simply, this method utilizes deproteinizing reagents added to the serum 
sample to reduce interfering proteins and a colorizing reagent (p -
bromoanaline) to produces a color when heated to 70 ° C for ten minutes. 
Following the color conversion, the sample is then placed in a 
spectrophotometer at 520 nm and the absorption is read. 
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Cryptosporidium parvum commonly infects the small intestine and 
can disrupt the nutrient absorption of its host (5). As was mentioned 
previously, disruption can occur from the damage caused to the villi through 
the infection process. Presently, malabsorption of carbohydrates from mouse 
intestine infected with C. parvum is not well understood. 
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OBJECTIVES AND HYPOTHESES 
The uncertainties of malabsorption previously mentioned have led to 
the following objectives and hypotheses for this study . 
Objective 1: Determine any correlation between infection of the villi and 
decreased absorption of nutrients. 
Hypothesis 1: Infection of the brush border of the small intestine leads to 
damage of absorptive capacities of cells, which causes nutrient contents to be 
greater in feces than in the blood . 
Objective 2: Evaluate the potential of D-xylose, an easily monitored 
carbohydrate not commonly found in blood, to measure intestinal absorption 
alterations caused by C. parvum infection. 
Hypothesis 2: A readily detected monosaccharide, such as D-xylose, will 
reveal that its serum blood levels are measurably lowered in infected mice. 
Objective 3: Monitor the effects of dexamethasone, an immunosuppressant, 
on absorptive alterations caused by C. parvum. 
Hypothesis 3: The effects of dexamethasone, a glucocorticosteriod, will not 
significantly alter absorption of D-xylose in C. parvum infected mice. 
Objective 4: Develop an effective diagnostic, if possible, to detect C. parvum 
affected malabsorption and therefore reduce production losses. 
Hypothesis 4: Early C.parvum infection of the small intestine alters 
absorption and can be monitored by monosaccharide administration. 
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MATERIALS AND METHODS 
Oocysts used in this investigation were generated by infecting a one day 
old Holstein calf using procedures outlined by Yang and Healey (21). The 
feces were mixed with 5% potassium dichromate solution and stored at 4 °C. 
Fecal collections were strained and oocysts purified using discontinuous 
sucrose gradient centrifugation (2). Briefly, the process of discontinuous 
sucrose gradients involves two contrasting sugar solutions: a 4:1 
water/sucrose and a 2:1 water/sucrose. Sugar solutions were layered in a 
centrifuge tube and 20 ml of strained feces were overlaid and centrifuged at 
1500 x g for 25 minutes. Oocysts were recovered from the interface layer of the 
two sucrose solutions. Collections were saline-washed and resuspended in 
2.5% potassium dichromate. This process wa s repeated to purify the oocysts, 
and the final collection was suspended in 2.5% potassium dichromate and 
refrigerated at 4°C. 
Female C57BL/ 6N mice approximately six to eight weeks of age were 
purchased from Taconic Inc. and housed in the Laboratory Animal Research 
Center at Utah State University. Mice were housed in plastic cages (5 
mice/ cage) with wire tops and received food and water ad libitum. 
Mice were randomly assigned to one of the following treatment groups 
(Figure 1.): 1) Non-immunosuppressed, non-infected, given D-xylose 
2) Immunosuppressed, non-infected, given D-xylose 
3) Immunosuppressed, infected, given D-xylose 
4) Immunosuppressed, infected, not given D-xylose . 
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Group 1 #mice /group I 
No DEX, No infection, given D-xylose 10 
All test mice p Group2 
mice contained ,; given DEX, No infection, given D-xylose 5 
in cages at the ~ Group3 
LARC 
given DEX, infected , given D-xylose 
14 
Group 4 
given DEX, infected, no D-xylose 
7 
Figure 1. Identification of four test groups of mice randomly assigned 
dexamethasone, C. parvum infection and D-xylose administration including 
the number of mice per group. Mice were immunosuppressed and infected 
but were not given D-xylose until the day of the digestion experiment. 
Purified oocysts were prepared for mouse infection by washing once in 
bleach, twice in sterilized Hank's balanced saline solution, and once with 
sterile RPMI 1640 (Sigma Chem. Co.) to remove the potassium dichromate. 
Seven days postimmunosuppression, mice were infected with C. parvum by 
intragastric administration of 104 oocysts/mouse, using a 22-gauge straight 
feeding needle. 
D-xylose administration. Twelve hours prior to D-xylose 






trial. To determine D-xylose quantities to be administered, mice were 
weighed 24 hr prior to the digestion experiment. The calculated dosage was 
25 mg D-xylose per gram body weight. D-xylose samples were prepared in 
advance and appropriate dosage for each individual mouse placed in a 
prelabeled 2 ml microcentrifuge tube and administered to each animal using 
a 22 gauge feeding needle when the trial was initiated. 
Sacrificing mice and sample collection. Immediately prior to 
sacrificing, mice were removed from their cages and held briefly in a laminar 
flow hood to allow collection of feces. Collections were placed in labeled 2 ml 
microcentrifuge tubes and suspended in potassium dichromate. Collected 
feces were stored at 4° C until Immunoflourescent assay (IFA) could be 
completed. 
Mice were sacrificed in two divisions to allow a more accurate analysis 
since the D-xylose absorption curve had not been completely determined at 
this time. Randomly selected mice from each group were sacrificed at either 
45 or 90 minutes postadministration. Blood was immediately extracted from 
the chest cavity and placed into 2 ml microcentrifuge tubes, labeled, and 
allowed to clot. The entire gastrointestinal tract was harvested and placed in 
15 ml of 10% formalin in a 50 ml conical centrifuge tube. 
Processing blood samples. Microcentrifuge tubes containing clotted 
blood were centrifuged at 1000 x g for 5 min. The serum was collected and 
placed in a new microcentrifuge tube and stored at 0° C. Analysis of serum 
samples was carried out according to the procedure outlined by Dahlqvist (7) 
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with some modifications to adjust for reduced sample quantity. The analysis 
procedure began with 10µ1 serum samples being pipetted into 70 µl of water 
plus 10µ1 of barium hydroxide and 10µ1 of zinc sulfate . This was centrifuged 
at 1000 x g for 5 min. Sixty microliters of the supernatant were placed into 
duplicate tubes and 300 µl of para-bromoanaline (Sigma Chem. Co.) added . 
One of the duplicate tubes was placed in a 70°C water bath for 10 min and the 
othe r was set aside and utilized as a spectroscopy blank. The heated tube was 
removed from the water bath and all tubes were placed in darkness at room 
temperature for 70 minutes. D-xylose concentration was 
spectrophotometrically measured at 520 nm . The absorption was measured 
using the unheated tube as a blank and calibrating the spectrophotometer for 
each sample. Tubes were read within 30 min of removal from darkness . A 
calculation of absorbance of the sample to absorbance of a standard D-xylose 
preparation was performed on the results to determine the blood D-xylose 
concentration . 
Fecal analysis. Fecal collections were analyzed for oocyst concentration 
using the IFA staining technique (1). This was achieved by first using an 
inoculating loop to apply smears on glass slides approximately one inch in 
diameter. Smears were allowed to dry for 30 min and were then flame fixed. 
Smears were treated with 80 µl of anti-oocyst IgM and incubated at 37° C for 30 
min. Slides were washed three times using phosphate buffered saline (PBS). 
The second antibody, a fluorescent labeled anti-mouse IgM, was applied at 80 
µl per slide. Slides were again incubated at 37° C for 30 minutes and washed 
three times with PBS. Two drops of glycerol/PBS were applied and cover 
slips were placed on the slides and preparations were examined using an 
ultraviolet light microscope (Carl Zeiss, Germany) with a 40x objective. The 
oocysts were quantified with a single pass through the center of the smear. 
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Histological examination of tissues. Two regions of the small intestine 
were examined, the terminal ileum and proximal duodenum . The regions 
were approximately 1 cm in length and embedded in paraffin. Thin (4µm) 
sections of the tissues were stained with hematoxylin and eosin . The 
prepared slide was read using a light microscope with a l00x oil immersion 
objective. Infection was noted by the colonization of the villi with small 
(4µm in diameter) spherical oocysts attached to the lumenal side of the villi 
or located within the crypts. The level of infection was calculated using ten 
random countings of oocysts in the villi. Countings were made from the 
apex of one villous to the apex of an adjacent villous . 
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RESULTS AND DISCUSSION 
Fecal analysis. Mouse fecal collections were examined using the IFA 
technique to determine parasites intensity in each of the four treatment 
groups. Significant differences existed between fecal oocyst concentrations of 
treated and control mice (Figure 2). Groups 3 and 4 had well established 
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Figure 2. Number of oocysts per ocular field using the IFA technique to 
analyze a sample fecal smear. 
Histological examination of tissues. The site of greatest colonization 
by the parasite is typically the terminal regions of the small intestine. The 
histological examination confirmed that there were highly significant 
differences between the colonization of the terminal ileum and the proximal 
duodenum (Figure 3). There was also significant swelling of the villi which 
resulted in a loss of the finger-like morphology. The terminal ileum of 
infected groups had an average oocysts per villi ratio of 40 (Figure 3). 
Differences among the infected groups were also seen in the significant 
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GROUP 
• AVG. OOCYST/ILEUM SECTION 
Iii AVG. OOCYST/DUODENUM SECTION 
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Figure 3. Cryptosporidium parvum colonization in the proximal duodenum 
and the terminal ileum. Note the overwhelming differences in infection 
rates. 
D-xylose analysis . Positive absorption of D-xylose was correlated with 
the specific treatment groups given D-xylose (Figure 4). There was no 
significant difference of D-xylose absorbed between the 45 and 90 minute 
collection groups. The control groups of this experiment returned expected 
low values for D-xylose absorption. 
Within the 45-minute collection group, there was a significantly higher 
amount of D-xylose absorbed from the immunosuppressed non-infected 
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group two than the non-immunosuppressed, non-infected control group one 
(Figure. 4). The greatest observed amount absorbed occurred in the 
immunosuppressed, infected group 3. 
Relatively similar trends were noted in the 90-minute collection group . 
There was, however, a significant difference seen in the immunosuppresed, 
non infected group . It had an eighteen percent lower absorption value than 
the control group and a thirty-seven percent lower absorption value than the 
infected group . This can be explained by the maximum absorption times for 
D-xylose in the mouse. After the administration of D-xylose there is a peak of 
D-xylose absorbed into the blood at approximately 60 minutes, the absorption 
then rapidly drops off over the next 60 minutes(20). 
There is also a noted variation between the nonimmunosuppressed, 
noninfected groups at both 45 and 90 minutes and the immunosuppressed 
infected groups . The immunosuppressed groups were an average 11 percent 
higher then nonimmunosuppressed groups. The individual groups along 
with the number in each group, the time of sampling and the type of 












4NNY 4YNY 4YYY 4YYN 9NNY 9YNY 9YYY 9YYN 
Group 
one two three four one two three four 
1------------------45 minu tes------------1 1--------------90 minutes---------------- I 
Figure 4. Comparison of the D-xylose absorbance among the different 
treatment groups. 
Table 1. Details the separate groups including the number of mice in each 
group, the time of sampling and the individual treatments given or not 
given. 
Number Min. for Sampling lmSup Infection Xylose 
4NNY 4 45 No No Yes 
4YNY 2 45 Yes No Yes 
4YYY 7 45 Yes Yes Yes 
4YYN 4 45 Yes Yes No 
9NNY 6 90 No No Yes 
9YNY 3 90 Yes No Yes 
9YYY 7 90 Yes Yes Yes 
9YYN 3 90 Yes Yes No 
21 
A repeat analysis was performed on the original serum samples using 
the same procedures and the results are shown in Figure 5. There were the 
same trends noted in the original examination though the absorption 











1 NNY 2 YNY 3 YYY 4YYN 1 NNY 2 YNY 3YYY 4 YYN 
Group 
one two three four one two three four 
1--------------45 min u tes---------------1 1---------------90 min u tes-------------1 
Figure 5. Additional comparison of the differences among the groups in the 
absorption of D-xylose. Note that the same trends are seen in the repeat 
analysis as were originally noted and the overall lower absorption percentage. 
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SUMMARY AND CONCLUSIONS 
Both the fecal and the histological examinations gave positive results 
for infection. In all mice that had been infected, a significant colonization had 
occurred. Histological preparations exhibited definitive damage to the 
epithelial tissues including villous atrophy and hyperplasia. From these 
examinations it follows that previously documented malabsorption should 
have been measured in the tissues, provided the proper malabsorption test 
agent was used (5, 11, 12, 16). 
D-xylose analysis. Data analysis revealed that no correlation existed 
between C. parvum infection and intestinal D-xylose absorption. There were 
subtle differences between 45 and 90-minute collection groups, although an 
absorption curve for humans exists in the literature which indicates that D-
xylose absorption should be similar during these time periods . 
Further analysis revealed that there was a positive correlation between 
DEX administration and intestinal D-xylose absorption. Results conflicted 
with our original hypothesis that DEX would not have interfering effects on 
the test. The effects of a glucocorticoid on the positive absorption of D-xylose 
from the intestine is great enough that its appearance masks the effects of 
cryptopsoridiosis on D-xylose absorption. 
In agreement with published texts, there were differences in the site of 
absorption, depending on the species . In the mouse there is a greater D-xylose 
absorption in the proximal areas and this absorption decreased further down 
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the intestinal tract (9, 20). Since there was a greater infection in distal then 
proximal intestinal sections, there is a high probability that the absorption 
analysis of an agent absorbed from proximal region of the intestine would be 
altered. This explanation, in conjunction with the effects of DEX, provides 
some understanding for the absorption increase of D-xylose in infected 
compared to noninfected individuals. The exact reasons for absorption site 
differences are not fully understood at this time. 
Conclusions . This experiment demonstrated that D-xylos e absorption is not 
a good determinant to evaluate altered absorption in the adult C57BL/6N 
mouse model due to cryptosporidiosis. The interfering affects of DEX, in 
conjunction with physiological differences in the mouse model, confound 
the malabsorption results when D-xylose is used. The effects of the 
immunosuppressive agent DEX on the absorption of the pentose nutrient can 
be of assistance to future experiments . Increased absorption of D-xylose in 
subjects receiving DEX can explain the increased weight gain in mice 
immunosuppresed for some time and future tests examining the health of 
the patient need to take this into consideration. 
For further malabsorption studies, results of this experiment suggest 
the following reagents; 1) Sucrose, because it has been shown greater 
amounts absorbed in the distal intestine sections than in proximal sections, 
therfore it would better detail any loss of absorptive capacity due to C. parvum 
infection and/ or 2) Lipid, due to its absorption into fecal materials which 
would eliminate the variation caused by a glucocorticoid on absorption into 
blood. It is also be suggested that further studies be completed on the 
physiological mechanisms of the mouse model before conclusions about C. 
parvum induced malabsorption can be reached . 
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